Drug Shortage Report for NAPROXEN-NA
Report ID | 28244 |
Drug Identification Number | 00887056 |
Brand name | NAPROXEN-NA |
Common or Proper name | NAPROXEN-NA |
Company Name | PRO DOC LIMITEE |
Market Status | MARKETED |
Active Ingredient(s) | NAPROXEN SODIUM |
Strength(s) | 275MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | M01AE |
ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2017-11-06 |
Estimated end date | |
Actual end date | 2018-07-26 |
Shortage status | Resolved |
Updated date | 2018-07-27 |
Company comments | Discontinued |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2925 BOULEVARD INDUSTRIEL LAVAL, QUEBEC CANADA H7L 3W9 |
Company contact information | 2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2018-07-27 | English | Compare |
v5 | 2018-07-26 | French | Compare |
v4 | 2018-07-26 | English | Compare |
v3 | 2017-11-07 | English | Compare |
v2 | 2017-11-06 | French | Compare |
v1 | 2017-11-06 | English | Compare |
Showing 1 to 6 of 6